Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Exp Med ; 204(9): 2213-24, 2007 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-17724125

RESUMO

Specific mutations in the human gene encoding the Wiskott-Aldrich syndrome protein (WASp) that compromise normal auto-inhibition of WASp result in unregulated activation of the actin-related protein 2/3 complex and increased actin polymerizing activity. These activating mutations are associated with an X-linked form of neutropenia with an intrinsic failure of myelopoiesis and an increase in the incidence of cytogenetic abnormalities. To study the underlying mechanisms, active mutant WASp(I294T) was expressed by gene transfer. This caused enhanced and delocalized actin polymerization throughout the cell, decreased proliferation, and increased apoptosis. Cells became binucleated, suggesting a failure of cytokinesis, and micronuclei were formed, indicative of genomic instability. Live cell imaging demonstrated a delay in mitosis from prometaphase to anaphase and confirmed that multinucleation was a result of aborted cytokinesis. During mitosis, filamentous actin was abnormally localized around the spindle and chromosomes throughout their alignment and separation, and it accumulated within the cleavage furrow around the spindle midzone. These findings reveal a novel mechanism for inhibition of myelopoiesis through defective mitosis and cytokinesis due to hyperactivation and mislocalization of actin polymerization.


Assuntos
Actinas/metabolismo , Citocinese , Doenças Genéticas Ligadas ao Cromossomo X/metabolismo , Mitose , Neutropenia/metabolismo , Neutropenia/patologia , Proteína da Síndrome de Wiskott-Aldrich/metabolismo , Animais , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/metabolismo , Proliferação de Células/efeitos dos fármacos , Aberrações Cromossômicas , Cromossomos Humanos , Citocinese/efeitos dos fármacos , DNA , Depsipeptídeos/farmacologia , Doenças Genéticas Ligadas ao Cromossomo X/patologia , Proteínas de Fluorescência Verde/metabolismo , Humanos , Camundongos , Mitose/efeitos dos fármacos , Proteínas Mutantes/metabolismo , Poliploidia , Proteínas Recombinantes de Fusão/metabolismo , Transgenes
2.
Pediatrics ; 121(4): e998-1002, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18316354

RESUMO

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome is a rare X-linked disorder that usually presents in early childhood with immune enteropathy, diabetes mellitus, and other autoimmune complications. The disease is caused by mutations in the forkhead box P3 gene, a transcription factor that is essential for the development and function of regulatory T cells. This population of cells plays an essential role in controlling immune responses and preventing autoimmunity. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome is often initially treated with immunosuppressive drugs, but only allogeneic hematopoietic stem cell transplantation has offered the possibility of cure. We recently performed an unrelated donor transplant in a child with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome by using a reduced-intensity conditioning regimen. This transplant provided a rare opportunity to gain valuable insight into the regeneration of the immune system after transplantation. Clinical recovery was associated with the emergence of regulatory T cell populations, the majority of which expressed memory phenotype markers and raised important questions about the origin and longevity of the FOXP3(+) regulatory T cell pool.


Assuntos
Fatores de Transcrição Forkhead/metabolismo , Doenças Genéticas Ligadas ao Cromossomo X/terapia , Transplante de Células-Tronco de Sangue Periférico/métodos , Poliendocrinopatias Autoimunes/diagnóstico , Poliendocrinopatias Autoimunes/terapia , Linfócitos T Reguladores/imunologia , Seguimentos , Fatores de Transcrição Forkhead/genética , Expressão Gênica , Doenças Genéticas Ligadas ao Cromossomo X/genética , Doenças Genéticas Ligadas ao Cromossomo X/imunologia , Sobrevivência de Enxerto , Humanos , Lactente , Masculino , Poliendocrinopatias Autoimunes/genética , Reação em Cadeia da Polimerase , Enteropatias Perdedoras de Proteínas/genética , Enteropatias Perdedoras de Proteínas/imunologia , Enteropatias Perdedoras de Proteínas/terapia , Medição de Risco , Síndrome , Linfócitos T Reguladores/metabolismo , Transplante Homólogo , Resultado do Tratamento
3.
Mol Ther ; 15(2): 355-60, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17235314

RESUMO

Retroviral transfer of the Herpes Simplex thymidine kinase (HSVTK) suicide gene to donor T cells has been used as a safety strategy against graft-versus-host disease following allogeneic stem cell transplantation. The feasibility of this strategy in human studies has been demonstrated, but a number of limitations have become apparent. Preactivation of donor lymphocytes using mitogens or monoclonal antibodies is essential for retroviral transduction, but can compromise subsequent T-cell function in vivo. We report the application of lentiviral vectors for transduction of T cells in cytokine culture, without activation through the T-cell receptor. Using vectors encoding either enhanced green fluorescent protein or a truncated CD34/mutant HSVTK fusion selection/suicide construct, we investigated the properties of T cells after gene modification. We found that following cytokine stimulation, a fraction of T cells undergoes division, and transgene expression occurred predominantly in these cells. Antiviral and alloreactive responses were preserved in these populations, and in contrast to fully activated T cells, there was minimal perturbation of regulatory T-cell numbers. We conclude that the use of interleukin-7 for lentiviral transduction offers the greatest potential for gene transfer to T cells without loss of function, and is favored for the clinical production of suicide gene modified T cells.


Assuntos
Vetores Genéticos/genética , Lentivirus/genética , Linfócitos T/metabolismo , Transfecção/métodos , Citocinas/farmacologia , Citometria de Fluxo , Genes Transgênicos Suicidas/genética , Terapia Genética/métodos , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Humanos , Interleucina-7/genética , Interleucina-7/metabolismo , Simplexvirus/genética , Linfócitos T/citologia , Linfócitos T/efeitos dos fármacos , Timidina Quinase/genética , Timidina Quinase/metabolismo
4.
Blood ; 108(7): 2182-9, 2006 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-16804117

RESUMO

Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent bacterial infections, and maturation arrest in the bone marrow. Although many cases have mutations in the ELA2 gene encoding neutrophil elastase, a significant proportion remain undefined at a molecular level. A mutation (Leu270Pro) in the gene encoding the Wiskott-Aldrich syndrome protein (WASp) resulting in an X-linked SCN kindred has been reported. We therefore screened the WAS gene in 14 young SCN males with wild-type ELA2 and identified 2 with novel mutations, one who presented with myelodysplasia (Ile294Thr) and the other with classic SCN (Ser270Pro). Both patients had defects of immunologic function including a generalized reduction of lymphoid and natural killer cell numbers, reduced lymphocyte proliferation, and abrogated phagocyte activity. In vitro culture of bone marrow progenitors demonstrated a profound reduction in neutrophil production and increased levels of apoptosis, consistent with an intrinsic disturbance of normal myeloid differentiation as the cause of the neutropenia. Both mutations resulted in increased WASp activity and produced marked abnormalities of cytoskeletal structure and dynamics. Furthermore, these results also suggest a novel cause of myelodysplasia and that male children with myelodysplasia and disturbance of immunologic function should be screened for such mutations.


Assuntos
Mutação , Neutropenia/congênito , Neutropenia/genética , Proteína da Síndrome de Wiskott-Aldrich/genética , Animais , Células da Medula Óssea/citologia , Células da Medula Óssea/metabolismo , Células COS , Proliferação de Células , Criança , Pré-Escolar , Chlorocebus aethiops , Humanos , Elastase de Leucócito/metabolismo , Linfócitos/citologia , Masculino , Neutropenia/metabolismo , Células U937 , Proteína da Síndrome de Wiskott-Aldrich/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA